Wesfarmers Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Wesfarmers şirketinin toplam hissedar öz sermayesi A$8.6B ve toplam borcu A$4.8B olup, bu da borç-öz sermaye oranını 55.4% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla A$27.3B ve A$18.7B dir. Wesfarmers 'in FAVÖK'ü A$3.8B faiz karşılama oranı 10 dur. Şirketin A$835.0M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

55.4%

Borç/özkaynak oranı

AU$4.76b

Borç

Faiz karşılama oranı	10x
Nakit	AU$835.00m
Eşitlik	AU$8.59b
Toplam yükümlülükler	AU$18.72b
Toplam varlıklar	AU$27.31b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: WF3 'nin kısa vadeli varlıkları ( A$9.4B ) kısa vadeli yükümlülüklerini ( A$8.2B ) aşıyor.

Uzun Vadeli Yükümlülükler: WF3 'un kısa vadeli varlıkları ( A$9.4B ) uzun vadeli yükümlülüklerini ( A$10.5B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: WF3 'nin net borç/öz sermaye oranı ( 45.7% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: WF3 şirketinin borç/öz sermaye oranı son 5 yılda 30.4% seviyesinden 55.4% seviyesine yükseldi.

Borç Kapsamı: WF3 'nin borcu işletme nakit akışı ( 96.6% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: WF3 'in borcuna ilişkin faiz ödemeleri EBIT ( 10 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Wesfarmers Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Wesfarmers Limited to Report Fiscal Year 2025 Results on Aug 28, 2025

Now 21% overvalued after recent price rise

Now 21% overvalued after recent price rise

Wesfarmers Limited Announces Resignation of Robert Geoffrey Scott as Director

Final dividend of AU$1.07 announced

Full year 2024 earnings released: EPS: AU$2.26 (vs AU$2.18 in FY 2023)

Macquarie and Wesfarmers Reportedly Join the Race for $3 Billion I-MED Sale

Now 20% overvalued after recent price rise

Private Equity Reportedly Pursues Ramsay

Now 21% overvalued

Wesfarmers Limited Announces Executive Changes

Wesfarmers Reportedly Runs the Ruler over Ramsay Health Care

First half dividend of AU$0.91 announced

Wesfarmers Limited Announces Dividend for the Six Months Ended December 31, 2023, Payable on March 27, 2024

First half 2024 earnings released: EPS: AU$1.26 (vs AU$1.22 in 1H 2023)

Wesfarmers Limited, Annual General Meeting, Oct 31, 2024

Now 20% undervalued

TPG Capital Reportedly Tests Buyer Interest for the $3.5 Billion-Plus Greencross

Full year 2023 earnings released: EPS: AU$2.18 (vs AU$2.08 in FY 2022)

Wesfarmers Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on October 5, 2023

Wesfarmers Limited Announces Management Changes

Wesfarmers Reportedly Among Suitors for Alinta Assets

MD, CEO & Director recently sold €5.5m worth of stock

First half 2023 earnings released: EPS: AU$1.22 (vs AU$1.07 in 1H 2022)

Wesfarmers Limited, Annual General Meeting, Oct 26, 2023

Wesfarmers Limited to Report Q2, 2023 Results on Feb 15, 2023

Wesfarmers Limited to Report Fiscal Year 2023 Results on Aug 25, 2023

Wesfarmers Limited Announces Ordinary Fully Franked Dividend for the Period of Six Months Ended June 20, 2022, Payable on October 6, 2022

Full year 2022 earnings released: EPS: AU$2.08 (vs AU$2.10 in FY 2021)

Wesfarmers Limited, Annual General Meeting, Oct 27, 2022

Less than half of directors are independent

An unknown buyer acquired a 2.1% stake in Coles Group Limited (ASX:COL) from Wesfarmers Limited (ASX:WES).

JB Hi-Fi Reportedly Enters the Jaycar Race

Non Executive Director recently bought €162k worth of stock

Non-Executive Director recently bought €51k worth of stock

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

Wesfarmers Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 30, 2022

Wesfarmers Limited Provides Preliminary Earnings Guidance for the Half Year Ended December 31, 2021

Upcoming dividend of AU$2.00 per share

Less than half of directors are independent

Independent Non-Executive Director recently bought €70k worth of stock

Director Sharon Warburton has joined 5th company board

Director Sharon Warburton has joined 5th company board

Director Sharon Warburton has joined 5th company board

Director Sharon Warburton has joined 5th company board

Director Sharon Warburton has joined 5th company board

Director Sharon Warburton has joined 5th company board

Full year 2021 earnings released: EPS AU$2.10 (vs AU$1.43 in FY 2020)

Wesfarmers, Brookfield Eye Icon

Wesfarmers Limited, Annual General Meeting, Oct 21, 2021

First half 2021 earnings released: EPS AU$1.23 (vs AU$1.00 in 1H 2020)

Revenue misses expectations

Wesfarmers Limited and Sociedad Química y Minera de Chile S.A. Announces Joint Approval of Mt Holland Lithium Project Final Investment Decision

New 90-day high: €35.32

Wesfarmers Limited Appoints Anil Sabharwal as Director

New 90-day high: €33.36

New 90-day high: €32.33

Wesfarmers Limited to Report First Half, 2021 Results on Feb 18, 2021

Wesfarmers Limited Announces Appointment of Anil Sabharwal to the Board

New 90-day high: €30.94

New 90-day high: €30.85

Wesfarmers Limited Announces Retirement of Diane Smith-Gander AO as Non-Executive Director

Wesfarmers Limited Not Provides Earnings Guidance for the Financial Year of 2021

Full year earnings released - EPS €1.43

New 90-day high - €29.16

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin